Z-1078-2026 Class II Ongoing
FDA device recall Z-1078-2026 was initiated by Elekta, Inc. on Dec 10, 2025 and is designated Class II. Reason for recall: Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial… The recall status is ongoing. Affected quantity: 1.
Recall details
- Product Type
- Devices
- Report Date
- Jan 21, 2026
- Initiation Date
- Dec 10, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1
Product description
MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)
Reason for recall
Using oncology information system that manages workflow may result in overtreatment if:Plan delivered with Particle Therapy IHE-RO TDW-II interface,With one field per fraction or last field partial treatment,Partial treatment occurs followed by treatment field interruptions with manually recorded partial treatment,Then treatment unit doesn't check meterset value so partial treatment delivered twice
Distribution pattern
US Nationwide distribution in the state of TX.
Code information
MOSAIQ v 3.10.200, and 3.1.1.0 up to and including v 3.2.3.1 with Particle Base. Software Versions: 3.10.200, 3.1.1.0, 3.1.2.0, 3.1.3.0, 3.1.3.1, 3.1.3.2, 3.1.3.3, 3.1.3.4, 3.2.0.0, 3.2.1.0, 3.2.1.1, 3.2.1.2, 3.2.1.3, 3.2.1.4, 3.2.2.0, 3.2.2.1, 3.2.3.0, 3.2.3.1 UDI-DI: 07340201500026, 07340201500071
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1078-2026
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026